These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34884950)

  • 1. A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma.
    Papanota AM; Karousi P; Kontos CK; Artemaki PI; Liacos CI; Papadimitriou MA; Bagratuni T; Eleutherakis-Papaiakovou E; Malandrakis P; Ntanasis-Stathopoulos I; Gavriatopoulou M; Kastritis E; Avgeris M; Dimopoulos MA; Scorilas A; Terpos E
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.
    Papanota AM; Tsiakanikas P; Kontos CK; Malandrakis P; Liacos CI; Ntanasis-Stathopoulos I; Kanellias N; Gavriatopoulou M; Kastritis E; Avgeris M; Dimopoulos MA; Scorilas A; Terpos E
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
    Papadimitriou MA; Papanota AM; Adamopoulos PG; Pilala KM; Liacos CI; Malandrakis P; Mavrianou-Koutsoukou N; Patseas D; Eleutherakis-Papaiakovou E; Gavriatopoulou M; Kastritis E; Avgeris M; Dimopoulos MA; Terpos E; Scorilas A
    Br J Cancer; 2022 Jan; 126(1):79-90. PubMed ID: 34718359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Expression of MicroRNAs in the Bone Marrow of Multiple Myeloma Patients and their Relationship to Cytogenetic Aberrations.
    Attia HRM; Abdelrahman AH; Ibrahim MH; Eid MM; Eid OM; Sallam MT; El Gammal MM; Kamel MM
    Curr Pharm Biotechnol; 2020; 21(13):1394-1401. PubMed ID: 32196445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Li J; Zhang M; Wang C
    J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.
    Papadimitriou MA; Soureas K; Papanota AM; Tsiakanikas P; Adamopoulos PG; Ntanasis-Stathopoulos I; Malandrakis P; Gavriatopoulou M; Sideris DC; Kastritis E; Avgeris M; Dimopoulos MA; Terpos E; Scorilas A
    J Transl Med; 2023 Apr; 21(1):245. PubMed ID: 37024879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
    Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in urine as diagnostic biomarkers for multiple myeloma.
    Li J; Wang C; Meng Q; Hu Z; Hu M; Zhang M
    Int J Lab Hematol; 2021 Apr; 43(2):227-234. PubMed ID: 33068078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma.
    Unno K; Zhou Y; Zimmerman T; Platanias LC; Wickrema A
    Leuk Lymphoma; 2009 Nov; 50(11):1865-71. PubMed ID: 19883314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
    Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
    Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.